MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

Search

ResMed Inc

Fechado

SetorSaúde

249.35 1.89

Visão Geral

Variação de preço das ações

24h

Atual

Mín

243.44

Máximo

250.11

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

25.114

88.032

Rendimento de Dividendos

0.89

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+17.28% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.89%

2.26%

Próximos Ganhos

29 de jan. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2B

36B

Abertura anterior

247.46

Fecho anterior

249.35

Sentimento de Notícias

By Acuity

28%

72%

62 / 373 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de jan. de 2026, 21:14 UTC

Grandes Movimentos do Mercado

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 de jan. de 2026, 19:23 UTC

Aquisições, Fusões, Aquisições de Empresas

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 de jan. de 2026, 17:41 UTC

Grandes Movimentos do Mercado

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 de jan. de 2026, 15:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Advent International Leads InPost Takeover Offer, Sky News Says

6 de jan. de 2026, 15:37 UTC

Grandes Movimentos do Mercado

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record High -- Market Talk

6 de jan. de 2026, 23:35 UTC

Conversa de Mercado

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 de jan. de 2026, 23:19 UTC

Conversa de Mercado

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 de jan. de 2026, 22:53 UTC

Conversa de Mercado

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 de jan. de 2026, 22:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 de jan. de 2026, 22:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de jan. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de jan. de 2026, 21:12 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

6 de jan. de 2026, 21:12 UTC

Conversa de Mercado

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 de jan. de 2026, 20:59 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 de jan. de 2026, 20:01 UTC

Conversa de Mercado

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 de jan. de 2026, 19:52 UTC

Conversa de Mercado

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 de jan. de 2026, 19:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 de jan. de 2026, 19:08 UTC

Aquisições, Fusões, Aquisições de Empresas

OneStream to Go Private Through $6.4B Hg Acquisition

6 de jan. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

6 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

6 de jan. de 2026, 15:57 UTC

Conversa de Mercado

Crude Futures Ease Back From Early Gains -- Market Talk

6 de jan. de 2026, 15:34 UTC

Conversa de Mercado
Ganhos

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 de jan. de 2026, 15:27 UTC

Conversa de Mercado

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

17.28% parte superior

Previsão para 12 meses

Média 292.25 USD  17.28%

Máximo 345 USD

Mínimo 260 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

6

Comprar

6

Manter

0

Vender

Sentimento

By Acuity

62 / 373 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat